Narrow-Band UVB Therapy and Topical Calcineurin Inhibitors for the Treatment of Paediatric Vitiligo in Real Clinical Practice

Abyaneh, M. Y., Griffith, R. D., Falto-Aizpurua, L., Nouri, K. (2014). Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: Mechanisms and efficacies. J. Eur. Acad. Dermatol. Venereol., 28, 1610–1622.10.1111/jdv.1261925073648 Search in Google Scholar

Alikhan, A., Felste,, L. M., Daly, M., Petronic-Rosic, V. (2011). Vitiligo: A comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histpathology, etiology, and work-up. J. Amer. Acad. Dermatol., 65, 473–491.10.1016/j.jaad.2010.11.06121839315 Search in Google Scholar

Brazzeli, V., Prestinari, F. (2005). Useful treatment of vitiligo in 10 children with UV-B-narrow-band (311 nm). Pediatr. Dermatol., 22, 257–261.10.1111/j.1525-1470.2005.22319.x15916579 Search in Google Scholar

Chen, G. Y., Hsu, M. M., Tai, H. K. (2005). Narrow-band UVB treatment of vitiligo in Chinese. J. Dermatol., 10, 793–800.10.1111/j.1346-8138.2005.tb00847.x16361730 Search in Google Scholar

Cui, J., Shen, L. Y., Wang, G. C. (1991). Role of hair follicles in the repigmentation of vitiligo. J. Invest. Dermatol., 97, 410–416.10.1111/1523-1747.ep124809971714927 Search in Google Scholar

Esfandiarpour, I., Ekhlasi, A., Farajzadeh, S., Shamsadini, S. (2009). The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: A double- blind, placebo-controlled clinical trial. J. Dermatol. Treat., 20, 14–18.10.1080/0954663080215505718608735 Search in Google Scholar

Fai, D., Cassano, N., Vena, G. A. (2007). Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: A review of 110 patients. J. Eur. Acad. Dermatol. Venereol., 21, 916–920.10.1111/j.1468-3083.2006.02101.x17659000 Search in Google Scholar

Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J. (2008). Guideline for the diagnosis and management of vitiligo. Brit. J. Dermatol., 159, 1051–1076.10.1111/j.1365-2133.2008.08881.x19036036 Search in Google Scholar

Grimes, P. E., Morris, R., Avaniss-Aghajani, E., Soriano, T., Meraz, M., Metzger, A. (2004). Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J. Amer. Acad. Dermatol., 51, 52–61.10.1016/j.jaad.2003.12.03115243524 Search in Google Scholar

Hirobe, T. (2005). Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res., 18, 2–12.10.1111/j.1600-0749.2004.00198.x15649147 Search in Google Scholar

Iannella, G., Greco, A., Didon, D., Didona, B., Granata, G., Manno, A., Pasquariello, B., Magliulo, G. (2016). Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmun. Rev., 15, 335–343.10.1016/j.autrev.2015.12.006 Search in Google Scholar

Kang, H. Y., Choi, Y. M. (2009). FK 506 increases pigmentation and migration of human melanocytes. Brit. J. Dermatol., 155, 1037–1040.10.1111/j.1365-2133.2006.07467.x Search in Google Scholar

Kanwar, A. J., Dogra, S. (2006). Narrow-band UVB for the treatment of generalized vitiligo in children. Clin. Exp. Dermatol., 45, 63–65. Search in Google Scholar

Klahan, S., Asawanonda, P. (2009). Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: A randomized, controlled study. Clin. Exp. Dermatol., 34, 1029–1030.10.1111/j.1365-2230.2009.03712.x Search in Google Scholar

Lan, C. C., Che, G. S., Chiou, M. H., Wu, C. S., Chang, C. H., Yu, H. S. (2005a). FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: Possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Brit. J. Dermatol., 153 (3), 498–505.10.1111/j.1365-2133.2005.06739.x Search in Google Scholar

Lan, C. C., Chen, G. S., Chiou, M. H. (2005b). FK 506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes. Brit. J. Dermatol., 153, 496–505.10.1111/j.1365-2133.2005.06739.x Search in Google Scholar

Lee, K. Y., Jeon, S. Y., Hong, J. W., Choi, K. W., Lee, C. Y., Choi, S. J., Kim, J. H., Song, K. H., Kim, K. H. (2013). Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: A proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment. J. Eur. Acad. Dermatol. Venereol., 27, 609–616.10.1111/j.1468-3083.2012.04498.x Search in Google Scholar

Lotti, T., Buggiani, G., Troiano, M. (2008). Targeted and combination treatment for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol. Ther., 21, 20–S26. Search in Google Scholar

Majid, I. (2010). Does topical tacrolimus ointment enhance the efficacy of narrow-band ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol. Photoimmunol. Photomed., 26, 230–234.10.1111/j.1600-0781.2010.00540.x Search in Google Scholar

Mehrabi, D., Pandya, A. G. (2006). A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch. Dermatol., 142, 927–929.10.1001/archderm.142.7.927 Search in Google Scholar

Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M. (2002). New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res., 15, 87–92.10.1034/j.1600-0749.2002.1o049.x Search in Google Scholar

Njoo, M., Bos, M. S., Westerhof, W. (2000). Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J. Amer. Acad. Dermatol., 42, 245–253.10.1016/S0190-9622(00)90133-6 Search in Google Scholar

Nordal, E. J., Guleng, G. E., Rönnevig, J. R. (2011). Treatment of vitiligo with narrowband-UVB (TL 01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J. Eur. Acad. Dermatol. Venereol., 25, 1440–1443.10.1111/j.1468-3083.2011.04002.x21466589 Search in Google Scholar

Ongenae, K., Beelaert, L., van Geel, N., Naeyaert, J. M. (2006). Psychosocial effects of vitiligo. J. Eur. Acad. Dermatol. Venereol., 20, 1–8.10.1111/j.1468-3083.2005.01369.x16405601 Search in Google Scholar

Ponsonby, A. L., Lucas, R. M., van der Mei, I. A. (2005). UVR, vitamin D and three autoimmune diseases — multiple sclerosis, type I diabetes, rheumatoid arthritis. Photochem. Photobiol., 81, 1267–1275.10.1562/2005-02-15-IR-44115971932 Search in Google Scholar

Satyanarayan, H. S., Kanwar, J. A., Parsad, D., Vinay, K. (2013). Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: A randomized intra-individual open comparative trial. Indian J. Dermatol. Venereol. Leprol., 79, 525–527.10.4103/0378-6323.11309123760325 Search in Google Scholar

Seirafi, H., Farnaghi, F., Firooz, A., Vasheghani-Farahani, A., Allirezale, N. S., Dowlati, Y. (2007). Pimecrolimus cream in repigmentation of vitiligo. Dermatology, 214, 253–259.10.1159/00009959217377388 Search in Google Scholar

Senft, D., Ronai, Z. A. (2016). Immunogenic, cellular, and angiogenic drivers of tumour dormancy: A melanoma view. Pigment Cell Melanoma Res., 1, 27–42.10.1111/pcmr.1243226514653 Search in Google Scholar

Sisti, A., Sisti, G., Oranges, C. M (2016). Effectiveness and safety of topical tacrolimus for repigmentation in vitiligo: A comprehensive literature review. An. Bras. Dermatol., 91, 187–195.10.1590/abd1806-4841.20164012486156627192518 Search in Google Scholar

Taieb, A., Alomar, A., Böhm, M., Dell’anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., Jouary, T. (2013). Guidelines for the management of vitiligo: The European Dermatology Forum consensus. Brit. J. Dermatol., 168, 5–19.10.1111/j.1365-2133.2012.11197.x22860621 Search in Google Scholar

Taieb, A., Picardo, M. (2010). Epidemiology, definitions and classification. In: Vitiligo. Springer, Berlin-Heidelberg, pp. 13–24.10.1007/978-3-540-69361-1_2 Search in Google Scholar

Taieb, A., Picardo, M., VETF Members (2007). The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Res., 20, 27–35.10.1111/j.1600-0749.2006.00355.x17250545 Search in Google Scholar

Taieb, A., Picardo, M. (2009). Clinical practice: Vitiligo. New Eng. J. Med., 360, 160–169.10.1056/NEJMcp080438819129529 Search in Google Scholar

Tran, C., Lubbe, J., Sorg, O. (2005). Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hair less mouse epidermis. Dermatology, 211, 341–347.10.1159/00008850516286744 Search in Google Scholar

Westerhof, W., d’Ischia, M. (2007). Vitiligo puzzle: The pieces fall in place. Pigment Cell Res., 20, 345–359.10.1111/j.1600-0749.2007.00399.x17850508 Search in Google Scholar

Whitton, M. E., Pinart, M., Batchelor, J., Lushe, C., Leonardi-Bee, J., González, U. (2010). Interventions for vitiligo. Cochrane Database Syst. Rev., 20 (1), CD003263.10.1002/14651858.CD003263.pub420091542 Search in Google Scholar

Wu, C. S., Yu, C. L., Lan, C. C. E., Yu, H. S. (2004). Narrow-band ultraviolet B stimulates proliferation and migration of cultured melanocytes. Exp. Dermatol., 13, 755–763.10.1111/j.0906-6705.2004.00221.x15560759 Search in Google Scholar